PATUSKY CHRISTOPHER
SEC Form 4 insider trading activity
PATUSKY CHRISTOPHER has filed 5 SEC Form 4 filings (9 transaction rows) across 1 company, with disclosures dating back to 2025. 5 of those filings fall inside the rolling window. Most recent filing: Nov 10, 2026.
On the most recent filing, PATUSKY CHRISTOPHER is listed as Director at UNITED THERAPEUTICS Corp. Inside the rolling window, PATUSKY CHRISTOPHER reported no open-market purchases and 4 open-market sales totaling $3.4M in UTHR. The largest disclosed transaction in the window is a sale of 2,910 UTHR shares on Apr 24, 2026, worth $1.7M.
Companies traded
Other insiders at UTHR
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$3.4M
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has PATUSKY CHRISTOPHER made?
PATUSKY CHRISTOPHER has filed 5 SEC Form 4 filings (9 transaction rows) across 1 company since 2025.
Which companies does PATUSKY CHRISTOPHER trade?
PATUSKY CHRISTOPHER has filed SEC Form 4 disclosures for 1 company, including UTHR.
When was PATUSKY CHRISTOPHER's most recent SEC Form 4 filing?
PATUSKY CHRISTOPHER's most recent SEC Form 4 filing on Tracefour is dated Nov 10, 2026.
What is PATUSKY CHRISTOPHER's total buy and sell value in the current window?
Inside the rolling retention window, PATUSKY CHRISTOPHER bought $0 and sold $3.4M based on SEC Form 4 filings.
What was PATUSKY CHRISTOPHER's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 2,910 UTHR shares on 2026-04-24, worth $1.7M, per SEC Form 4 filings.